Frequent health care utilisation and avascular necrosis are associated with cannabis use in adults with sickle cell disease

Hope Miodownik; Susanna A. Curtis; Ugochi Olivia Ogu; Christopher Bradford; Joanna L. Starrels; Chinazo O. Cunningham; Julia H. Arnsten; Jaeun Choi; Ruth Eisenberg; Caterina P. Minniti

doi:10.1111/bjh.17901

Frequent health care utilisation and avascular necrosis are associated with cannabis use in adults with sickle cell disease

Hope Miodownik
, Susanna A. Curtis
, Ugochi Olivia Ogu
, Christopher Bradford
, Joanna L. Starrels
, Chinazo O. Cunningham
, Julia H. Arnsten
, Jaeun Choi
, Ruth Eisenberg
, Caterina P. Minniti

Research output: Contribution to journal › Letter › peer-review

2 Scopus citations

Original language	English
Pages (from-to)	e41-e44
Journal	British Journal of Haematology
Volume	196
Issue number	5
DOIs	https://doi.org/10.1111/bjh.17901
State	Published - Mar 2022
Externally published	Yes

Keywords

Clinical
Sickle Cell Anemia
Sickle Cell Disease

Access to Document

10.1111/bjh.17901

Cite this

@article{bcef80ed31e045b7b5ba2d68459ed9cd,

title = "Frequent health care utilisation and avascular necrosis are associated with cannabis use in adults with sickle cell disease",

keywords = "Clinical, Sickle Cell Anemia, Sickle Cell Disease",

author = "Hope Miodownik and Curtis, \{Susanna A.\} and \{Olivia Ogu\}, Ugochi and Christopher Bradford and Starrels, \{Joanna L.\} and Cunningham, \{Chinazo O.\} and Arnsten, \{Julia H.\} and Jaeun Choi and Ruth Eisenberg and Minniti, \{Caterina P.\}",

note = "Funding Information: Dr Curtis is supported by K23HL151884, Dr Cunningham is supported by K24DA036955, Dr Starrels is supported by K24DA046309, and Drs Starrels, Cunningham, and Arnsten are supported by R01DA044171. Funding Information: Drs Miodownik, Bradford, Cunningham, Arnsten, Choi, and Eisenberg report no conflicts of interest or competing interests. Dr Curtis declares consultancy for Global Blood Therapeutics. Dr Ogu declares Consultancy for Vertex Pharmaceuticals and Novo‐Nordisk, Speaker Bureau for Global Blood Therapeutics. Dr Minniti declares Advisory roles to Novartis, Global Blood Therapeutics, Roche, Forma, Bluebird Bio, Emmaus Life Science, CSL‐ Behring, Chiesi, Novo‐Nordisk and Research support from Global Blood Therapeutics and Bayer. Dr Starrels declares research support from the FDA‐mandated Opioid Post‐Marketing Requirement Consortium. ",

year = "2022",

month = mar,

doi = "10.1111/bjh.17901",

language = "English",

volume = "196",

pages = "e41--e44",

journal = "British Journal of Haematology",

issn = "0007-1048",

publisher = "John Wiley and Sons Inc.",

number = "5",

}

TY - JOUR

T1 - Frequent health care utilisation and avascular necrosis are associated with cannabis use in adults with sickle cell disease

AU - Miodownik, Hope

AU - Curtis, Susanna A.

AU - Olivia Ogu, Ugochi

AU - Bradford, Christopher

AU - Starrels, Joanna L.

AU - Cunningham, Chinazo O.

AU - Arnsten, Julia H.

AU - Choi, Jaeun

AU - Eisenberg, Ruth

AU - Minniti, Caterina P.

N1 - Funding Information: Dr Curtis is supported by K23HL151884, Dr Cunningham is supported by K24DA036955, Dr Starrels is supported by K24DA046309, and Drs Starrels, Cunningham, and Arnsten are supported by R01DA044171. Funding Information: Drs Miodownik, Bradford, Cunningham, Arnsten, Choi, and Eisenberg report no conflicts of interest or competing interests. Dr Curtis declares consultancy for Global Blood Therapeutics. Dr Ogu declares Consultancy for Vertex Pharmaceuticals and Novo‐Nordisk, Speaker Bureau for Global Blood Therapeutics. Dr Minniti declares Advisory roles to Novartis, Global Blood Therapeutics, Roche, Forma, Bluebird Bio, Emmaus Life Science, CSL‐ Behring, Chiesi, Novo‐Nordisk and Research support from Global Blood Therapeutics and Bayer. Dr Starrels declares research support from the FDA‐mandated Opioid Post‐Marketing Requirement Consortium.

PY - 2022/3

Y1 - 2022/3

KW - Clinical

KW - Sickle Cell Anemia

KW - Sickle Cell Disease

UR - https://www.scopus.com/pages/publications/85117193954

U2 - 10.1111/bjh.17901

DO - 10.1111/bjh.17901

M3 - Letter

C2 - 34661288

AN - SCOPUS:85117193954

SN - 0007-1048

VL - 196

SP - e41-e44

JO - British Journal of Haematology

JF - British Journal of Haematology

IS - 5

ER -